{"id":243113,"date":"2026-05-11T09:00:18","date_gmt":"2026-05-11T09:00:18","guid":{"rendered":"https:\/\/www.europesays.com\/se\/243113\/"},"modified":"2026-05-11T09:00:18","modified_gmt":"2026-05-11T09:00:18","slug":"uppsalabolag-tar-in-210-miljoner-for-klinisk-studie","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/243113\/","title":{"rendered":"Uppsalabolag tar in 210 miljoner f\u00f6r klinisk studie"},"content":{"rendered":"<p>Dicot Pharma har beslutat om en nyemission p\u00e5 upp till 210 miljoner kronor f\u00f6r att finansiera en planerad fas IIb-studie inom erektil dysfunktion.<\/p>\n<p>            den 11 maj 2026 10:28<\/p>\n<p>Nyemissionen, som ger f\u00f6retr\u00e4desr\u00e4tt f\u00f6r bolagets befintliga aktie\u00e4gare \u00e4r till 80 procent s\u00e4krad genom teckningsf\u00f6rbindelser och garanti\u00e5taganden, enligt ett pressmeddelande.<\/p>\n<p>Uppsalabaserade Dicot utvecklar LIB-01, en l\u00e4kemedelskandidat som designats f\u00f6r att till skillnad fr\u00e5n exempelvis Viagra ha en l\u00e5ngtidsverkande effekt p\u00e5 erektionsf\u00f6rm\u00e5gan genom att den p\u00e5verkar nerv- och k\u00e4rlstrukturer, inte bara v\u00e4vnaden.<\/p>\n<p>\n                        Ja, tack! Jag vill prenumerera p\u00e5 Life science Sweden under 1 m\u00e5nad. Ingen bindningstid Du f\u00e5r bland annat tillg\u00e5ng till e-tidning, nyhetsbrev och plusartiklar p\u00e5 hemsidan\n                    <\/p>\n<p>\n                    F\u00e5 tillg\u00e5ng till allt inneh\u00e5ll p\u00e5 Life Science Sweden\n                <\/p>\n<p>\n                    Ingen bindningstid eller kortinformation kr\u00e4vs\n                <\/p>\n<p>\n                        G\u00e4ller endast personlig prenumeration.\n                    <\/p>\n<p>                                            <a v-for=\"(project, index) in projects\" v-show=\"index &lt; max || showAll\" v-bind:href=\"'https:\/\/www.projektagenten.se\/project\/' + project.id\" target=\"_blank\" class=\"article-project\"><\/p>\n<p>                                                {{ project.name }}<br \/>\n                                                L\u00e4s om projektet<br \/>\n                                            <\/a><\/p>\n<p>                                                Alla relaterade projekt<\/p>\n","protected":false},"excerpt":{"rendered":"Dicot Pharma har beslutat om en nyemission p\u00e5 upp till 210 miljoner kronor f\u00f6r att finansiera en planerad&hellip;\n","protected":false},"author":2,"featured_media":243114,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[72,70,71,34,31,33,32,30],"class_list":{"0":"post-243113","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ekonomi","8":"tag-business","9":"tag-economy","10":"tag-ekonomi","11":"tag-se","12":"tag-svenska","13":"tag-sverige","14":"tag-sweden","15":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116555128927852488","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/243113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=243113"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/243113\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/243114"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=243113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=243113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=243113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}